Market Research Logo

Hemostats Market – Global Forecasts to 2025

Hemostats Market – Global Forecasts to 2025

Global Hemostats Market – Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025

[83 pages report] This market research report includes a detailed segmentation of the global Hemostats market by type (active Hemostats, passive Hemostats, combination Hemostats), by product (thrombin-based Hemostats, gelatin-based Hemostats, collagen-based Hemostats, oxidized regenerated cellulose-based Hemostats, combination Hemostats, others), and by region (North America, Europe, Asia Pacific, Rest of the World)

  • verview of the Global Hemostats Market
Infoholic’s market research report predicts that the “Global Hemostats Market” will grow at a CAGR of 6.2% during the forecast period 2019–2025. The market has witnessed steady growth in the past few years and is sustaining due to the increasing number of surgical procedures, growing incidence of sports-related injuries, and increasing focus on effective blood loss management.



Increase in the number of outpatient procedures, increasing focus on emerging markets, and increase in healthcare spending are providing opportunities for the growth of the Hemostats market. Vendors are concentrating on new product launch across the therapeutic areas. The majority of the revenue is generated from the leading players in the market with sales dominated by B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Johnson & Johnson, Medtronic Plc, Advanced Medical Solution Group Plc, Pfizer, Biom’Up, Gelita GmbH, CryoLife Inc., Integra LifeScience, Z-Medica, and Teleflex (Vascular Solutions).

According to the Infoholic Research analysis, North America accounted for the largest share of the global Hemostats market in 2018. The Asia Pacific region is expected to witness the fastest growth rate due to the availability of a large patient pool, increasing surgeries, and rising healthcare expenditure.

By Product:
  • Thrombin-based Hemostats
  • Gelatin-based Hemostats
  • Collagen-based Hemostats
  • Oxidized Regenerated Cellulose-based Hemostats
  • Combination Hemostats
  • Others
Among the products, the higher efficacy has made thrombin-based Hemostats the major shareholder in the market. Combination agents are profiting from the highest growth rate as medical practitioner take on more complex and risky procedures that necessitate efficient, fast-acting products for successful control of bleeding.

By Type:
  • Active Hemostats
  • Passive Hemostats
  • Combination Hemostats
Active Hemostats hold a significant market share, followed by combination Hemostats. In June 2017, Ethicon received the FDA approval for Surgicel Powder Absorbable Haemostat.

By Regions:
  • North America
  • Europe
  • APAC
  • RoW
North America dominated the global Hemostats market in 2018. The significant share of the North American region comes from the US due to the accessibility to good quality healthcare and good reimbursement facilities.

Hemostats Market Research Competitive Analysis – Mergers & acquisitions have been the primary strategy followed by major players to maintain their leadership in the market. In 2017, Teleflex acquired Vascular Solutions. In March 2018, Baxter acquired RECOTHROM and PREVELEAK from Mallinckrodt plc to broaden surgical haemostat and sealant portfolio. New products launched are posing a threat to previously available products in the market. In January 2019, the US FDA approved the marketing of HEMOBLAST Bellows Laparoscopic Applicator for all minimally-invasive procedures. To aid this, Biom’Up has trained nearly 200 medical professionals in the US and Europe for the use of product far ahead of the launch.

Key Vendors:
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Johnson & Johnson
  • Medtronic Plc
  • Advanced Medical Solution Group Plc
  • Pfizer
Key Competitive Facts
  • Ethicon (J&J), Baxter International, and Pfizer are the three major players in the market.
  • The primary focus among the players in the market is to develop Hemostats that reduce significant time during the surgery procedure.
Benefits – The report provides complete details about the sub-segments of the Hemostats market. Through this report, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the disease management in the upcoming years along with details of the existing pure-play companies and new players entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:
  • Understanding the potential market opportunity with precise market size and forecast data.
  • A detailed market analysis focusing on the growth of the Hemostats industry.
  • Factors influencing the growth of the Hemostats market.
  • In-depth competitive analysis of dominant and pure-play vendors.
  • Prediction analysis of the Hemostats market in both developed and developing regions.
  • Key insights related to major segments of the Hemostats market.
  • Latest market trend analysis impacting the buying behavior of the consumers.
Key Stakeholders


1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market
1.3 Industry Trends
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Segmented Addressable Market
3.2.1 Characteristics of an Ideal Hemostatic Agent
3.2.2 Regulatory Scenario
3.3 Industry Trends
3.4 Related Market
3.4.1 Wound Biologics
3.4.1.1 Trends in the wound biologics market
4 Market Outlook
4.1 Reimbursement
4.2 Market Segmentation
4.3 Porter 5 (Five) Forces
5 Market Characteristics
5.1 Market Dynamics
5.1.1 Drivers
5.1.1.1 Increase in the number of surgical procedures
5.1.1.2 Growing incidence of sports-related injuries
5.1.1.3 Increasing focus on effective blood loss management
5.1.2 Restraints
5.1.2.1 Stringent regulatory approval process
5.1.2.2 High cost of hemostats
5.1.2.3 Availability of alternatives
5.1.3 Opportunities
5.1.3.1 Increase in healthcare spending
5.1.3.2 Increase in the number of outpatient procedures
5.1.3.3 Market expansion opportunities in emerging nations
5.1.4 DRO – Impact Analysis
5.2 Key Stakeholders
6 Products: Market Size and Analysis
6.1 Overview
6.2 Thrombin-based Hemostats
6.3 Gelatin-based Hemostats
6.4 Collagen-based Hemostats
6.5 Oxidized Regenerated Cellulose-based Hemostats
6.6 Combination Hemostats
6.7 Others
7 Types: Market Size and Analysis
7.1 Overview
7.2 Passive Hemostats
7.3 Active Hemostats
7.4 Combination Hemostats
8 Regions: Market Size and Analysis
8.1 Overview
8.2 North America
8.2.1 Overview
8.3 Europe
8.3.1 Overview
8.4 Asia Pacific
8.4.1 Overview
8.5 Rest of the World
8.5.1 Overview
9 Competitive Landscape
10 Vendors Profile
10.1 B. Braun Melsungen AG
10.2 Baxter International Inc.
10.3 Becton Dickinson and Company
10.4 Johnson and Johnson
10.5 Medtronic Plc (Covidien Plc)
10.6 Advanced Medical Solutions Group Plc
10.7 Pfizer
11 Companies to Watch for
11.1 Biom’Up
11.2 Gelita AG
11.3 CryoLife Inc.
11.4 Integra LifeSciences
11.5 Z-Medica
11.6 Teleflex (Vascular Solutions)
Annexure
Abbreviations
Tables
TABLE 1 HEMOSTATS PRODUCTS AND CATEGORIES
TABLE 2 HEMOSTATS MARKET REVENUE, BY PRODUCT, 2018–2025 ($MILLION)
TABLE 3 PRODUCT LIST
TABLE 4 HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION)
TABLE 5 PRODUCT LIST
TABLE 6 HEMOSTATS MARKET REVENUE, BY GEOGRAPHY, 2018–2025 ($MILLION)
TABLE 7 BUSINESS SUMMARY: B BRAUN MELSUNGEN AG
TABLE 8 BUSINESS SUMMARY: BAXTER INTERNATIONAL INC.
TABLE 9 BUSINESS SUMMARY: BECTON DICKINSON AND COMPANY
TABLE 13 BUSINESS SUMMARY: PFIZER
TABLE 14 BUSINESS SUMMARY: BIOM’UP
TABLE 15 BUSINESS SUMMARY: GELITA AG
TABLE 16 BUSINESS SUMMARY: CRYOLIFE INC
TABLE 17 BUSINESS SUMMARY: INTEGRA LIFESCIENCE
TABLE 18 BUSINESS SUMMARY: COMPANY NAME
TABLE 19 BUSINESS SUMMARY: TELEFLEX INCORPORATED
Charts
CHART 1 RESEARCH METHODOLOGY OF GLOBAL HEMOSTATS MARKET
CHART 2 HEMOSTATS MARKET REVENUE, 2018–2025 ($MILLION)
CHART 3 HEMOSTATS MARKET SEGMENTATION
CHART 4 PORTERS 5 FORCES ON HEMOSTATS MARKET
CHART 5 PEST ANALYSIS OF HEMOSTATS MARKET
CHART 6 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES
CHART 7 DRO - IMPACT ANALYSIS OF HEMOSTATS MARKET
CHART 8 KEY STAKEHOLDERS OF HEMOSTATS MARKET
CHART 9 HEMOSTATS MARKET SEGMENT REVENUE, BY PRODUCT, 2018 ($MILLION)
CHART 10 THROMBIN BASED HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION)
CHART 11 GELATIN BASED HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION)
CHART 12 COLLAGEN BASED HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION)
CHART 13 OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION)
CHART 14 COMBINATION HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION)
CHART 15 OTHER HEMOSTATS MARKET REVENUE, BY TYPE, 2018–2025 ($MILLION)
CHART 16 HEMOSTATS MARKET SEGMENT REVENUE, BY TYPE, 2018-2025 ($MILLION)
CHART 17 PASSIVE HEMOSTATS MARKET SEGMENT REVENUE, BY TYPE, 2018-2025 ($MILLION)
CHART 18 ACTIVE HEMOSTATS MARKET SEGMENT REVENUE, BY TYPE, 2018-2025 ($MILLION)
CHART 19 COMBINATION HEMOSTATS MARKET SEGMENT REVENUE, BY TYPE, 2018-2025 ($MILLION)
CHART 20 HEMOSTATS MARKET BY REGIONAL SEGMENTATION, 2018 (%)
CHART 21 HEMOSTATS MARKET BY REGIONAL SEGMENTATION, 2025 (%)
CHART 22 HEMOSTATS MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($MILLION)
CHART 23 HEMOSTATS MARKET REVENUE IN US 2018 (%SHARE)
CHART 24 HEMOSTATS MARKET REVENUE IN EUROPE, 2018–2025 ($MILLION)
CHART 25 HEMOSTATS MARKET REVENUE IN EUROPE, BY COUNTRIES 2018 (%SHARE)
CHART 26 HEMOSTATS MARKET REVENUE IN ASIA PACIFIC, 2018–2025 ($MILLION)
CHART 27 HEMOSTATS MARKET REVENUE IN REST OF THE WORLD, 2018–2025 ($MILLION)
CHART 28 PRODUCT MATRIX

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report